戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 bercular treatment and most of whom were HIV seropositive.
2      Mothers of 157 infants (83.5%) were CMV-seropositive.
3 n starting ART aged older than 24 weeks were seropositive.
4 uded, 209 (68%) of whom were cytomegalovirus seropositive.
5                         One patient was dual seropositive.
6         Out of the 250 cases, 155 (62%) were seropositive.
7     All patients were Epstein-Barr virus IgG seropositive.
8  patients were female, and 42 (30%) were HIV seropositive.
9 serologically screened individuals, 26% were seropositive.
10 4 years (IQR: 27-44), and 130 (28%) were HIV seropositive.
11  12 years of chronological age for those CMV seropositive.
12                Two American robins were also seropositive.
13 were HCV seropositive; 26 (3.1%) were HTLV-1-seropositive.
14  of 217 of 839 participants (25.9%) were HCV seropositive; 26 (3.1%) were HTLV-1-seropositive.
15 2%; 95% confidence interval, 0.7%-4.3%) were seropositive, 3 with documented travel and 1 who had an
16 stem (PNS) manifestations, 39% were LGI1-IgG seropositive (7% had solely neuropathy or pain).
17 2.7 to 96.1) in the subcutaneous group, were seropositive, a difference of -9.2 percentage points (95
18 though individuals in all professions tested seropositive, abattoir workers (10 of 97; 10.3%) were si
19 8% in HIV-seronegative adults and 71% in HIV-seropositive adults (odds ratio, 6.2; 95% confidence int
20  frequency and quantity are high among HSV-2-seropositive adults in sub-Saharan Africa, including per
21 es plasma interleukin 6 (IL-6) levels in CMV-seropositive adults who are critically ill.
22                                    Among CMV-seropositive adults with critical illness due to sepsis
23 ys (November 10, 2016) that included 160 CMV-seropositive adults with either sepsis or trauma and res
24 t pre-existing neutralizing responses in RSV seropositive adults.
25 ge, resulting in around 98% of infants being seropositive against type 2.
26            We prospectively monitored 63 CMV-seropositive allo-HCT recipients with a CMV-specific enz
27 IgG-seronegative patients who receive an IgG-seropositive allograft do not develop CMV infection desp
28 dies investigating the infectiousness of HIV-seropositive and -seronegative index cases have been per
29        We assessed the infectiousness of HIV-seropositive and -seronegative patients with tuberculosi
30 717 of 974 (73.6%) household contacts of HIV-seropositive and -seronegative tuberculosis cases (relat
31 npregnant asymptomatic adults who were HSV-2 seropositive and 2 in HSV-2-serodiscordant couples.
32      A total of 49 542 HSCT patients, 29 349 seropositive and 20 193 seronegative, were identified fr
33 oid, mucosal and secretory tissues of 44 CMV seropositive and 28 seronegative donors.
34 d for diagnosing dengue fever, 93 cases were seropositive and 67 cases were seronegative.
35 novel susceptibility factors for PTLD in EBV-seropositive and EBV-seronegative individuals, respectiv
36 ean follow-up of 8.2 years, we observed (HCV seropositive and HCV seronegative, respectively) 107 and
37 ng and immunohistochemical analyses of HIV-1 seropositive and HIV-1 encephalitic human brain tissues
38 the frequency of genital HSV shedding in HIV-seropositive and HIV-seronegative men and women in Ugand
39 an immunodeficiency virus (HIV)-infected HCV-seropositive and incidence density-matched HCV-seronegat
40 rum and longitudinal outcome in 256 LGI1-IgG-seropositive and/or CASPR2-IgG-seropositive patients.
41 ngly, in both studies, immunization of HSV-1-seropositive animals had little effect on recurrent vagi
42 e against genital disease in naive and HSV-1-seropositive animals.
43                       A total of 2,139 HBsAg-seropositive, anti-HCV-seronegative, and treatment-naive
44 (+) T cells from HLA-A*02:01 positive, HSV-1 seropositive ASYMP and symptomatic (SYMP) individuals (w
45 ially studied HLA-A*02:01-positive and HSV-1-seropositive ASYMP individuals, the most frequent, robus
46 onors who were seropositive in 2005 remained seropositive at 5 years and maintained neutralizing anti
47 tion in 64% of all participants; among those seropositive at age 15-16 years, 84% were predicted to r
48 ldren in the subcutaneous group [94.7%] were seropositive at day 91, a difference of -9.3 percentage
49    Seven of 12 individuals were JCV antibody seropositive based on absorbance units.
50                           Most subjects were seropositive before MMR3 receipt, and very few had a sec
51 d 3 HEV reinfections among patients who were seropositive before transplantation through detection of
52 specificity of antibody responses in 370 WNV-seropositive blood donors.
53         Smokers were more likely to be HPyV9-seropositive but MCV-seronegative, and HPyV7 seropositiv
54 ents carrying KIR2DS4*00101 alleles were CMV seropositive, but not control individuals, and exhibited
55 ects with CSF-serum pairs, 26 were NMDAR1 AB seropositive, but only 1 was CSF positive.
56 is of neuromyelitis optica for 2 patients as seropositive by both ELISA and CBA.
57 the head and neck cancer GWAS limited to HPV-seropositive cases and an independent cervical cancer GW
58                         The age range of the seropositive cases was 1 to 78 years with the mean age o
59                                              Seropositive cases were tested additionally by fluoresce
60   We here assess DS-Cav1 F immunogenicity in seropositive cattle pre-exposed to bovine RSV, a virus c
61 V-serostatus (11 [48%] of 23 symptomatic HIV-seropositive child contacts vs two [7%] of 31 asymptomat
62  contacts vs two [7%] of 31 asymptomatic HIV-seropositive child contacts) or to only culture-confirme
63 in 250 classic (non-AIDS) KS cases, 280 KSHV-seropositive controls, and 576 KSHV-seronegative control
64                               Most (78%) had seropositive convalescent specimens.
65 7 of 12 (58.3%) seronegative recipients of a seropositive donor (positive donor/negative recipient [D
66 cially in patients receiving an organ from a seropositive donor (SHR, 1.92 [95% CI, 1.30-2.85]; P = .
67 ted that HHV-8 was likely transmitted by the seropositive donor at the time of transplantation.
68 ve patient, our data support selecting a CMV-seropositive donor if the patient receives a myeloablati
69 chimerism status in a subset of R+/D- and R+/seropositive donor patients.
70  8-DNA was detected in 6.8% and 2.9% of HHV8-seropositive donor samples by in-house nested PCR and qu
71 , were cytomegalovirus seropositive or had a seropositive donor, and underwent weekly plasma cytomega
72 plant, 3 (25%) of 12 HHV8-mismatch patients (seropositive donor/seronegative recipient) developed a p
73 eronegative recipients receiving organs from seropositive donors (D+R-) and 104 seropositive recipien
74 ope is robustly recognized by CD4 T cells of seropositive donors across diverse HLA haplotypes.
75                                              Seropositive donors also had no influence on relapse-fre
76 e analysis, recipients receiving grafts from seropositive donors had a higher risk of chronic GVHD th
77           Patients receiving grafts from EBV-seropositive donors had the same overall survival as pat
78                In seronegative patients with seropositive donors, the HR for chronic GVHD was 1.30 (9
79                In seropositive patients with seropositive donors, the HR was 1.24 (95% CI, 1.07 to 1.
80 D4(+) TH1 proliferation response only in CMV-seropositive donors.
81 31 of 34 renal transplant biopsies from HCMV-seropositive donors.
82             Thirty percent of men (486) were seropositive for >/=1 HPV type, and 25 men developed inc
83            PML risk increases in individuals seropositive for anti-John Cunningham virus (JC) antibod
84  that approximately 31.4% of 433 horses were seropositive for antibodies (Abs) against NPHV and appro
85 g was positive for Eurasian H5 viral RNA and seropositive for antibodies reactive to the Eurasian H5
86 a patient with NMOSD whose test results were seropositive for aquaporin-4 IgG and who had a hepatic m
87 who had ataxia, were 18 years or older, were seropositive for at least 1 neural autoantibody, had rec
88 in seroprevalence, at least 9% of males were seropositive for at least 1 of the 4 HPV types.
89 ttransplant: 78 (57%) of F-->M patients were seropositive for at least 1 of the 6 HY-Abs, and 3-month
90                        All participants were seropositive for at least 1 PyV, with seroprevalences ra
91 9 (3.8%) had IRB for BBV and 285 (1.7%) were seropositive for BBV, of whom half had a history of IRB
92 her in vaccinated than unvaccinated subjects seropositive for both antibody to hepatitis B surface an
93 mated that 302 of 469 (64.4%) red foxes were seropositive for canine adenovirus (CAV) by ELISA.
94 ong predictor of CNS involvement in patients seropositive for CASPR2-IgG or LGI1-IgG.
95 G6 IgA seropositive individuals (59.1%) were seropositive for celiac disease-related alleles compared
96                                     Patients seropositive for cytomegalovirus (CMV) and undergoing al
97 ls are expanded in patients with AAV who are seropositive for cytomegalovirus (CMV), and are associat
98 nts with APECED lacked Paneth cells and were seropositive for defensin-specific autoantibodies; the p
99           There were decreases in proportion seropositive for every HPV type across all age groups, m
100            Two of 207 (1%) participants were seropositive for H5 and 4 of 207 (2%) for H7 in 2011, co
101 Among state veterinarians, 4 of 37(11%) were seropositive for H7 and 1 of 37 (2.7%) for H5.
102 e found in healthy ASYMP individuals who are seropositive for HSV-1 but never had any recurrent herpe
103 entive interventions in asymptomatic persons seropositive for HSV-2.
104  Among 2 047 740 first-time donors, 104 were seropositive for HTLV-1 (prevalence, 5.1 cases/per 100 0
105 idence interval [CI], 4.1-6.1), and 300 were seropositive for HTLV-2 (prevalence, 14.7 cases/per 100
106  presentation, 16% of patients with BMD were seropositive for IgG and/or IgM antibody to B. miyamotoi
107 ter vaccination, all vaccinated rabbits were seropositive for IgG to F. tularensis lipopolysaccharide
108 d distribution; proportions of US population seropositive for measles and rubella; and measles-mumps-
109 Equally high proportions of the samples were seropositive for measles virus, mumps virus, or rubella
110 22) individuals older than 15 years might be seropositive for MERS-CoV in Saudi Arabia.
111                     Eighty-one patients were seropositive for NNC antibodies (most commonly PCA-1 [an
112      We determined the proportion of females seropositive for PV antibody by 5-year age strata, and a
113  initial TNF inhibitor treatment in patients seropositive for rheumatoid arthritis and naive to treat
114    While 8 of the primatologists tested were seropositive for SFV from a NWM, the spider monkey, none
115       Two groups of children born to mothers seropositive for T. cruzi were compared: 101 had congeni
116                                 The patients seropositive for TG6 showed a classic picture of ALS, si
117 ak strain, 86.9% (95% CI, 75.8 to 94.2) were seropositive for the 44/76-SL strain, for which there wa
118 f these vaccinees (95% CI, 94.1 to 100) were seropositive for the 5/99 strain and had a higher geomet
119                     Seventy-one percent were seropositive for the JC polyomavirus.
120   18 of 25 participants with sIBM (72%) were seropositive for the NT5c1A antibody.
121 nated and unvaccinated participants who were seropositive for the outbreak strain and for one closely
122 confidence interval [CI], 61.8 to 70.3) were seropositive for the outbreak strain, although the geome
123 e found significantly more frequently in the seropositive group.
124 e efficacy in herpes simplex virus 1 (HSV-1)-seropositive guinea pigs immunized and subsequently chal
125  with Iscomatrix and alum to HSV-1-naive or -seropositive guinea pigs.
126 onegative (HCMV(-)) individuals than in HCMV-seropositive (HCMV(+)) individuals.
127 y blood-derived T cells of 5 of 17 HSV-1/VZV-seropositive healthy adults but not in cord blood donors
128 t women, as well as CMV-seronegative and CMV-seropositive healthy adults, were included as controls.
129 le in the "natural" protection seen in HSV-1-seropositive healthy asymptomatic (ASYMP) individuals (w
130 y a role in the "natural" protection seen in seropositive healthy asymptomatic (ASYMP) individuals (w
131  as well as 26 HCMV-seronegative and 39 HCMV-seropositive healthy controls.
132 ccine in baseline Ad26-seronegative and Ad26-seropositive healthy volunteers.
133 dred fifty-six hepatitis B e antigen (HBeAg)-seropositive, hepatitis B surface antigen (HBsAg) carrie
134 nonuclear cell samples from 108 CMV- and EBV-seropositive HIV-infected men who have sex with men, who
135  are described in a prospective study of HCV-seropositive HIV-infected patients at Cipto Mangunkusomo
136 ose uptake by monocyte subpopulations in HIV-seropositive (HIV(+)) treatment-naive individuals (n = 1
137 d genital secretions were collected from HIV-seropositive (HIV+) Kenyan female sex workers (FSWs) (n
138 mononuclear cell (PBMC) samples from 107 CMV-seropositive, HIV-infected men who have sex with men, wh
139                     Treating everyone within seropositive households (63% population) would target 77
140 cells of 'humanized' HLA transgenic mice and seropositive human donors.
141                                              Seropositive human sera also neutralize Hendra virus and
142 ng-running community-recruited cohort of HIV-seropositive illicit drug users during a community-wide
143               A total of 115 cytomegalovirus seropositive, immunocompetent adults with critical illne
144                          All donors who were seropositive in 2005 remained seropositive at 5 years an
145 ven in susceptible individuals that are ACPA-seropositive in human arthritis.
146 sis contact investigation should include HIV-seropositive index cases in high disease burden settings
147 sis cases modified the infectiousness of HIV-seropositive indexes.
148 e for P. jirovecii; however, most adults are seropositive, indicating natural immune priming to this
149 ecific HLA antigen alleles; 13 of 22 TG6 IgA seropositive individuals (59.1%) were seropositive for c
150                 Here, whole blood of healthy seropositive individuals (n = 75), living in N.
151 eas HLA-B8 was a risk factor for PTLD in EBV-seropositive individuals (OR = 3.29, 95% CI = 1.52-7.09)
152 amma, perforin, and CD107a expression) in 76 seropositive individuals aged 70 years or older.
153 responses seen with age but suggest that CMV-seropositive individuals differ in their natural exposur
154           Across age groups, cytomegalovirus seropositive individuals displayed immunotypes character
155 responses were lower in P. falciparum lysate-seropositive individuals than in seronegative individual
156                              The mean age of seropositive individuals was significantly younger than
157 te controllers (ECs) are a rare group of HIV seropositive individuals who are able to control viral r
158 pandemic health problem, and the majority of seropositive individuals will eventually progress to AID
159                                       Of 148 seropositive individuals, 40 fulfilled inclusion criteri
160  frequencies in human cytomegalovirus (HCMV)-seropositive individuals, and these have been shown to h
161                                  In 100 HCMV-seropositive individuals, the GM3/17 polymorphism, serum
162                                    Among HCV-seropositive individuals, treated participants without S
163 to achieve a therapeutic effect in other HIV-seropositive individuals.
164  antigen targeted by CD8(+) T cells from HSV-seropositive individuals.
165 major Ag targeted by CD8(+) T cells from HSV-seropositive individuals.
166 of coronary heart disease in cytomegalovirus-seropositive individuals.
167 tners in stable or casual relationships with seropositive individuals.
168     Previously, we examined IgGs from 10 HSV-seropositive individuals; all neutralized virus and were
169 roup heterogeneity, suggesting a subgroup of seropositive-like cases within seronegative cases (PBUHM
170                                          CMV-seropositive lung transplantation recipients were includ
171                                        RhCMV-seropositive macaques, which shed RhCMV in saliva, were
172 fection and the first malaria episode (PfRH5-seropositive median: 71 days, PfRH5-seronegative median:
173 ions were observed for HPV 16 among baseline-seropositive men [adjusted HR, 1.37; 95% confidence inte
174 V 18 infection was significantly lower among seropositive men in the unadjusted model (HR, 0.22; 95%
175  titers of protective antibodies from highly seropositive mothers have not been studied in detail.
176 ific T-cell responses in breast milk of HCMV-seropositive mothers is not well defined.
177                           We enrolled 43 JCV-seropositive MS patients, including 32 on natalizumab mo
178 mune response is highly prevalent in all JCV-seropositive MS patients, regardless of treatment.
179 te race/ethnicity with highly active AQP4-ab-seropositive NMO (n = 6) and NMO spectrum disorder (n =
180 splants in which donor or recipient were CMV seropositive (non-D-/R-), compared with D- transplant or
181                         A high proportion of seropositive OLM cases had uveitis (34.19%) followed by
182   The most frequent clinical presentation of seropositive OLM cases were unilateral reduced vision an
183 tigen using matched T cells and MCs from CMV-seropositive or CMV-seronegative donors, and for antigen
184 2007, and Feb 28, 2013, were cytomegalovirus seropositive or had a seropositive donor, and underwent
185 men on antiretroviral therapy who were HSV-2 seropositive or seronegative and HIV-uninfected controls
186  influenced by whether the subjects were CMV seropositive or seronegative.
187            Females have higher odds of being seropositive (OR=2.30).
188 dren with PHIV and 97% of PHEU children were seropositive (P < .001).
189                         We included 2503 HCV-seropositive participants (540 with spontaneous HCV clea
190 A undetectability were analyzed in 431 HBeAg-seropositive participants and 1,708 HBeAg-seronegative p
191          PBMCs isolated from healthy CMV/EBV seropositive participants before (PRE) and immediately a
192 re included in the analytic sample (2278 HIV-seropositive participants contributed 20 477 visits and
193     Compared with HCV-negative controls, HCV-seropositive participants had an increased risk of liver
194 eview and meta-analysis was conducted of HIV-seropositive participants receiving ART compared with no
195 % to 27.7% (P < .001), and 48.4% of unlinked seropositive participants were linked to HIV care throug
196                                              Seropositive participants were more likely to require as
197           Facial weakness occurred in 50% of seropositive participants while it was only seen in 14%
198 tis D virus RNA among anti-hepatitis D virus seropositive participants.
199 fication products were obtained from 118 HCV-seropositive participants; subtypes 4k (in 47 participan
200                       Of 132 women with HSV2-seropositive partners, seroconversion was 36.4 per 100 p
201                                    For a CMV-seropositive patient, our data support selecting a CMV-s
202 was found in 44% of LGI1-IgG/CASPR2-IgG dual seropositive patients (one-third thymoma).
203 l therapy in immunocompetent cytomegalovirus seropositive patients admitted to the ICU with acute res
204 (null) cells were found predominantly in CMV-seropositive patients and expanded in the posttransplant
205 es amplified from HDV seroconverters and HDV-seropositive patients at baseline.
206 o the major CMV pp65 and IE-1 antigens in 15 seropositive patients at intermediate risk of CMV infect
207 cing lesions from 284 aquaporin-4 (AQP4)-IgG seropositive patients at Mayo Clinic from 1996 to 2014.
208                              Cytomegalovirus-seropositive patients demonstrated a greater fall in the
209 ailable from 96 of 118 consecutive PCA-2-IgG-seropositive patients identified during 1993-2016.
210 trospective review of the medical records of seropositive patients identified in the Mayo Clinic Neur
211 r, the importance of donor serostatus in CMV-seropositive patients is controversial.
212                                              Seropositive patients receiving grafts from seropositive
213  ischemia and reperfusion in cytomegalovirus-seropositive patients undergoing primary percutaneous co
214 utoantibodies against glutamatergic NMDAR in seropositive patients who cannot be clinically identifie
215                                     Among 70 seropositive patients whose medical records were availab
216 We assessed whether CD4+CD28- T cells in CMV seropositive patients with AAV are associated with arter
217 n strategy targeting an unselected cohort of seropositive patients with acute respiratory distress sy
218 gG serostatus was longitudinally assessed in seropositive patients with available serum samples and a
219 Recent data highlight the presence, in HIV-1-seropositive patients with lymphoma, of p17 variants (vp
220                                              Seropositive patients with seronegative donors did not h
221                                           In seropositive patients with seropositive donors, the HR w
222   In the first study, 889 untreated anti-HCV-seropositive patients without HCC symptoms were followed
223 possible cause of neurodegeneration in HIV-1-seropositive patients, which engages the ability of p17
224  256 LGI1-IgG-seropositive and/or CASPR2-IgG-seropositive patients.
225 elerated immunosenescence in cytomegalovirus-seropositive patients.
226  depleted for >/=3 months in cytomegalovirus-seropositive patients.
227 celerate immunosenescence in cytomegalovirus-seropositive patients.
228 rus-specific CD8(+) cells in cytomegalovirus-seropositive patients.
229 red as index, may further define PML risk in seropositive patients.
230 aphic factors and clinical manifestations of seropositive patients.
231 tion, but EBV DNAemia detection in low-risk (seropositive) patients has poor specificity as a biomark
232 NS3-1073 and NS5-2594 were expanded from HCV-seropositive persons by peptide stimulation in vitro or
233                              Cytomegalovirus-seropositive persons commonly lack detectable levels of
234 e same regardless of the proportion of HCVAb-seropositive persons in the cohort being tested.
235 rom each region in 28 immunocompetent, HSV-2-seropositive persons.
236 IBV was detected in 3 nasal swabs from PRRSV-seropositive pigs by real-time reverse transcription-PCR
237 tected in 3 nasal swabs collected from PRRSV-seropositive pigs by real-time RT-PCR and sequencing.
238 we preferentially included more samples from seropositive pigs than from seronegative pigs.
239                   Eligible patients were CMV-seropositive, positive for HLA-A*0201, aged 18-75 years,
240 of the TEMRA pool in chronic cytomegalovirus-seropositive postmyocardial infarction patients was asso
241     Prospective study involving 144 T. cruzi seropositive pregnant women.
242 jor histocompatibility complex (MHC) in 2782 seropositive RA cases and 4315 controls of Asian descent
243 -trend = 0.004) increased risk of developing seropositive RA compared with those who consumed no suga
244 t soda, is associated with increased risk of seropositive RA in women, independent of other dietary a
245                                     The mean seropositive rate for all PvTRAgs was 60.3%.
246  newly identified in this study and showed a seropositive rate of >50%.
247   Current dogma suggests risk is greatest in seropositive recipient (R+)/seronegative donor (D-) tran
248                               Two of 93 HHV8-seropositive recipients (2.1%) had viral replication in
249  time to onset of prophylaxis failure in CMV-seropositive recipients of allogeneic hematopoietic-cell
250 gans from seropositive donors (D+R-) and 104 seropositive recipients receiving antithymocyte globulin
251                                          For seropositive recipients unable to take prophylaxis, toxo
252                   Rate of reactivation among seropositive recipients was 2.2 and 16%.
253                         In patients who were seropositive, reduction in seizure frequency was associa
254                                          CMV-seropositive responders had significantly higher frequen
255  each HY-Ab was associated with a persistent seropositive response throughout the posttransplant foll
256 table anti-B. pseudomallei antibody, whereas seropositive results among neighborhood contacts was 5%
257 riority trial enrolled patients with active, seropositive rheumatoid arthritis and an inadequate resp
258 CI = 2.05-41.32), as did people who were HIV seropositive (RR = 4.06, 95% CI = 1.42-11.56).
259 e and the highly specific assays, 66 AQP4-Ab seropositive samples were used to establish the sensitiv
260 arasitology are also diagnosed in the field (seropositive [SERO]).
261 and outcomes did not differ significantly in seropositive, seronegative, and statin-associated cases.
262                                       NT5c1A seropositive sIBM cases had lower total Medical Research
263                            Participants with seropositive sIBM took significantly longer to get up an
264  CMV IgG-seronegative (sR(-)) and 86 CMV IgG-seropositive (sR(+)) patients.
265 immunogenicity subgroup of 1944 children had seropositive status for one or more dengue serotypes.
266 ation after cardiac death, hepatitis B and C seropositive status, cigarette use, diabetes, hypertensi
267 formance of a kidney biopsy, cytomegalovirus seropositive status, donation after cardiac death, hepat
268 ng human monoclonal antibody isolated from a seropositive subject.
269 al skin biopsy specimens obtained from HSV-2-seropositive subjects at the time of lesion onset up to
270 nd HLA indicated that the gut microbiomes of seropositive subjects differed from those of autoantibod
271 ression of IL-18Ralpha on NK cells from HCMV seropositive subjects do not fully explain these impaire
272 Bacteroides and Prevotella, respectively, in seropositive subjects with multiple versus one autoantib
273 age, CD4 and gender-matched HIV-infected CMV-seropositive subjects, and among 21 HIV-uninfected contr
274 he salivary microbial composition for 10 HIV-seropositive subjects, before and 6 months after highly
275 antibodies, IgG-94 and IgG-RC, isolated from seropositive subjects.
276 l and cellular immunity commonly seen in CMV seropositive subjects.
277  genome-wide epitopes were compared in HSV-1-seropositive symptomatic individuals (with a history of
278 ignificant proportion of patients may remain seropositive (the "serofast state").
279 immunoglobulin G antibody levels among those seropositive to CMV were also associated with shorter LT
280                 Among the controls, 88% were seropositive to H. pylori at baseline.
281         Ninety-five percent of controls were seropositive to H. pylori.
282 tralian states and calculated the proportion seropositive to HPV types 6, 11, 16, and 18.
283                     Importantly, individuals seropositive to saliva are 2.1 times more likely to deve
284      Approximately 97% of the population was seropositive to tetanus and diphtheria as defined by a p
285           Twenty-three patients (15.3%) were seropositive to TG6 IgA antibodies as opposed to only 5
286                 This study suggests that HIV-seropositive tuberculosis cases may be less infectious t
287                           Ninety-three HSV-2-seropositive Ugandan adults collected anogenital swab sp
288  Seropositive patients receiving grafts from seropositive unrelated donors had improved overall survi
289                                        HBeAg-seropositive vaccine failure HBV-carrier children were a
290  differences in biodiversity were evident in seropositive versus seronegative FDRs.
291                              The features of seropositive versus seronegative groups were compared an
292 otent (Neut50 < 0.1 mug/ml) nAbs from a DENV-seropositive volunteer immunized with the tetravalent va
293 a secretion assay (gamma-catch) from healthy seropositive volunteers and expanded in vitro.
294 eview, the 16 initial patients identified as seropositive were the subject of this study.
295 ring of a lung transplant recipient (A2, CMV seropositive) who received a HLA-B27 bilateral lung allo
296       Twenty-five patients who were AQP4-IgG seropositive with an initial STM represented 14% of init
297                          We compared (1) HCV-seropositive with HCV-seronegative participants and (2)
298 iated with HPV-16/18 between seronegative vs seropositive women (15-25 years) in the control arm (DNA
299       Among 49 ulcer specimens from 49 HSV-2 seropositive women, by PCR HSV-2 was recovered from 28 (
300                     Among 487 infants of 476 seropositive women, congenital T. cruzi infection was de

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top